A Phase 1 trial testing TG Therapeutics' CAR T-cell therapy azer-cel in progressive forms of MS is now recruiting across ...

"At first, I kind of laughed … But they were serious. I could just see the seriousness in their faces." In this book excerpt, Lise Barnéoud explores the limitations of DNA testing.

A new, highly sensitive cell therapy was able to wipe out three different kinds of solid tumors in mice, an important advance in an area where CAR-T cells have long struggled. But significant ...

A single infusion of stem cells helped frail older adults walk significantly farther.

Can fragments of tumor DNA in the blood predict whether chemotherapy will be effective? Researchers at the Princess Máxima ...

According to one analyst, the alliance and early data “validate” the oncology work of Vir, which was once purely an ...

A proof-of-concept study opens up an avenue for treating solid tumours that express low levels of a target antigen.

Juan Uribe's 15-year-old son Max needs a perfect stem cell donor match. His story went viral on social media, but the search ...

The microneedle patch about the size of a quarter samples key cells often missed in routine blood samples and biopsies.

UCSF is teaming up with Nektar to study NKTR-0165, an experimental antibody that activates the TNFR2 receptor, as a treatment for MS.

Researchers at Moffitt Cancer Center have identified distinct spatial tumor–immune ecosystems that predict whether patients with advanced non–small cell lung cancer will benefit from immunotherapy.